Focusing on Corneal Ectatic Disease: An In-Depth Conversation with J. Bradley Randleman, MD

The arrival of J. Bradley Randleman, MD, at Cleveland Clinic’s Cole Eye Institute bolsters an already strong corneal research team. Dr. Randleman’s focus is the identification and management of corneal ectatic diseases, the therapeutic potential of corneal cross-linking, and new optical technology that could improve keratoconus diagnosis and treatment.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy